Victory Capital Management Inc Rigel Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$1.12 - $1.57 $567 - $795	-507 Reduced 2.19%	22,637 $33,000
Q4 2023 Feb 05, 2024	BUY	$0.72 - $1.56 $3,142 - $6,809	4,365 Added 23.24%	23,144 $33,000
Q3 2023 Nov 06, 2023	BUY	$1.07 - $1.39 $47 - $61	44 Added 0.23%	18,779 $20,000
Q2 2023 Jul 27, 2023	SELL	$1.12 - $1.82 $489 - $795	-437 Reduced 2.28%	18,735 $24,000
Q1 2023 May 02, 2023	SELL	$1.25 - $2.0 $308 - $494	-247 Reduced 1.27%	19,172 $25,000
Q4 2022 Feb 09, 2023	SELL	$0.67 - $11.9 $5 - $95	-8 Reduced 0.04%	19,419 $29,000
Q3 2022 Nov 02, 2022	BUY	$1.1 - $12.2 $631 - $7,002	574 Added 3.04%	19,427 $23,000
Q2 2022 Aug 01, 2022	SELL	$0.67 - $3.19 $8 - $41	-13 Reduced 0.07%	18,853 $21,000
Q1 2022 May 04, 2022	SELL	$2.22 - $3.45 $641 - $997	-289 Reduced 1.51%	18,866 $45,000
Q4 2021 Feb 07, 2022	SELL	$2.36 - $3.57 $1,364 - $2,063	-578 Reduced 2.93%	19,155 $51,000
Q3 2021 Nov 02, 2021	SELL	$3.5 - $4.5 $2,257 - $2,902	-645 Reduced 3.17%	19,733 $72,000
Q2 2021 Aug 03, 2021	SELL	$3.09 - $4.54 $4,471 - $6,569	-1,447 Reduced 6.63%	20,378 $88,000
Q1 2021 May 04, 2021	SELL	$3.35 - $4.93 $1,805 - $2,657	-539 Reduced 2.41%	21,825 $75,000
Q4 2020 Feb 01, 2021	BUY	$2.35 - $3.74 $2,700 - $4,297	1,149 Added 5.42%	22,364 $78,000
Q3 2020 Nov 09, 2020	SELL	$1.78 - $4.13 $2,093 - $4,856	-1,176 Reduced 5.25%	21,215 $51,000
Q2 2020 Aug 07, 2020	SELL	$1.41 - $2.05 $954 - $1,387	-677 Reduced 2.93%	22,391 $41,000
Q1 2020 May 04, 2020	SELL	$1.27 - $3.0 $28,075 - $66,321	-22,107 Reduced 48.94%	23,068 $36,000
Q4 2019 Feb 06, 2020	BUY	$1.6 - $2.43 $35,216 - $53,484	22,010 Added 95.01%	45,175 $97,000
Q4 2019 Feb 04, 2020	SELL	$1.6 - $2.43 $25 - $38	-16 Reduced 0.07%	23,165 $52,000
Q3 2019 Nov 12, 2019	BUY	$1.63 - $2.62 $37,785 - $60,734	23,181 New	23,181 $43,000
Q2 2019 Aug 15, 2019	SELL	$2.02 - $2.61 $16,404 - $21,195	-8,121 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$2.6 - $3.59 $2,776 - $3,834	1,068 Added 15.14%	8,121 $26,000
Q1 2018 May 04, 2018	SELL	$3.54 - $4.54 $16,284 - $20,884	-4,600 Reduced 39.47%	7,053 $25,000
Q2 2017 Aug 07, 2017	BUY	N/A	11,653	11,653 $32,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account